Showing results (451-460 of 567) with videos related to

Sort By:
Pageof 57
Clinical Rheumatology|June 6, 2024
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 studyChristopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, et al.
Nature Reviews. Rheumatology|February 16, 2021
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus studyLourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Using Natural Language Processing to improve EHR Structured Data-based Surgical Site Infection SurveillanceJianlin Shi, Siru Liu, Liese C C Pruitt, et al.
Optics Letters|August 4, 2005
Two-dimensional mapping of electro-optic phase retardation in lithium niobate crystals by digital holographyM de Angelis, S De Nicola, A Finizio, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 16, 2024
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual SurveyMelissa P Zundell, Alexis R Ogdie-Beatty, Lourdes Perez-Chada, et al.
The Journal of Rheumatology|April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE StudyTien Nguyen, Melvin Churchill, Robert Levin, et al.
The New England Journal of Medicine|October 19, 2017
Tofacitinib or Adalimumab versus Placebo for Psoriatic ArthritisPhilip Mease, Stephen Hall, Oliver FitzGerald, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Single Cell Analysis of pBMCs of Psoriasis patients reveals distinct CD4+ T cell phenotypes associated with response to IL-23 blockadeKathryne E Marks, Anina Sun, Ifeoluwakiisi Adejoorin, et al.
Rheumatology and Therapy|August 19, 2023
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis RegistryPhilip J Mease, Alexis Ogdie, John Tesser, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Pageof 57